The largest database of trusted experimental protocols

5 protocols using sc 16982

1

Protein Expression Profiling in Spinal Cord

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein from the spinal cord tissue was purified using protein extraction reagents containing 1% protease and phosphatase inhibitors. The protein concentration of each sample was quantified with Carmassi Bradford reagents (Thermo). An equivalent amount of protein (60 µg) was separated by 10% SDS‐PAGE and transferred onto PVDF membranes (Bio‐Rad). After blocking with 5% (w/v) non‐fat milk, the membranes were further incubated with primary antibody solutions overnight at 4°C. The following primary antibodies were including: TrkA (ab‐76291, Abcam, 1:5000), FGFR1 (ab‐58516, Abcam, 1:1000), P‐AKT (sc‐514032, Santa Cruz, 1:1000), AKT (sc‐81434, Santa Cruz, 1:1000), P‐ERK (sc‐16982, Santa Cruz, 1:1000), ERK (sc‐514302, Santa Cruz, 1:1000), Bcl‐2 (60178‐1‐Ig, proteintech, 1:3000), Bax (60267‐1‐Ig, proteintech, 1:2000), cleaved caspase‐3 (sc‐373730, Santa Cruz, 1:500), GAP43 (ab75810, Abcam, 1:10 000), GFAP (ab7260, Abcam, 1:2000), NF‐200 (ab8135, Abcam, 1:5000) and GAPDH (K200057M, Solarbio, 1:5000). After three washed with TBST, the membranes were incubated with a 1:10 000 dilution of horseradish peroxidase‐conjugated secondary antibodies for 60 minutes at room temperature. Finally, signals were visualized by Chemi DocXRS + Imaging System (Bio‐Rad). All experiments were repeated three times.
+ Open protocol
+ Expand
2

Investigating CRC Cell Apoptosis Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
When CRC cells were treated with different doses of QFGs (05, 1 and 2 mg/mL) for 24 h, a cell lysis buffer containing a cocktail to lyse the cells was added. The bicinchoninic acid assay was used to detect the total protein concentrations, and 50 µg of total protein was used for electroblotting. Five percent skim milk was used to block the NC membranes, and then primary antibodies against Fas, FasL, p-PI3K and p-AKT (ab-110021, ab-15285, ab182651, ab38449; 1:1000, Abcam, CA, United States), p-ERK (sc-16982; 1:1000, Santa Cruz Biotechnology, CA, United States), cleaved-caspase-3, cleaved-caspase-8, cleaved-caspase-9, β-actin, Bcl-2 and Bax (#9662, #4790, #9508, #4967, #4223, #5023; 1:1000, Cell Signaling, Beverly, MA, United States), PI3K, AKT and ERK (13329-1-AP, 10176-2-AP, 16443-1-AP; 1:2000, Proteintech, United States) were added at 4 °C overnight. On the second day, the appropriate HRP-conjugated secondary antibodies (goat anti-mouse IgG secondary antibody, #L3032; goat anti-rabbit IgG secondary, #L3012; 1:5000, Signalway Antibody, PA, United States) were added and the SuperSignal West Pico Chemiluminescent Substrate was used to detect the signal.
+ Open protocol
+ Expand
3

Signaling Pathways in EL4 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
EL4 cells transfected overnight with pEGFP-C3-siOCILRP2 were stimulated with anti-CD3/CD28 antibodies. For the other two groups, EL4 cells were stimulated with or without anti-CD3/CD28 antibodies. Cell lysates were prepared in SDS sample buffer (Tris-HCl, SDS, and 20% glycerol) and detected using SDS-PAGE. The proteins were electrotransferred onto Immobilon-P PVDF membranes (0.45 µm, Millipore, USA) and probed with the appropriate primary antibodies against the following: p-Raf-1 (Ser 338) (sc-12358, Santa Cruz, 1∶200), caspase-8 p18 (G-1) (sc-166596, Santa Cruz, 1∶500), caspase-3 p17 (B-4) (sc-271028, Santa Cruz, 1∶500), JNK1 (D-6) (sc-137018, Santa Cruz, 1∶500), p-JNK1/2/3 (T183+Y185) pAb (BS4322, Bioworld Technology, 1∶500), ERK 1/2 (H-72) (sc-292838, Santa Cruz, 1∶200), p-ERK 1/2 (Thr202/Tyr204) (sc-16982, Santa Cruz, 1∶200), IκB-alpha (N-terminus) mAb (MB0106, Bioworld Technology, 1∶1000), β-actin (Sigma, 1∶5,000), and β-tubulin (Sigma, 1∶5000)). After incubation with a horseradish peroxidase-conjugated secondary antibody (Santa Cruz, 1∶10,000) for 3-4 h, the membranes were washed with PBST. Immunoreactivity was visualized using an ECL system (Perkin Elmer, USA), and densitometry scanning of the intensity of the bands was quantified using ImageJ.
+ Open protocol
+ Expand
4

Paeruptorin A Cell Signaling Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PA was purchased from ChemFaces (Wuhan, China). A stock solution of Paeruptorin A (PA) was made at a concentration of 100 mM in dimethyl sulfoxide (DMSO) and stored at −20 °C. Antibodies against cyclin D1 (sc-717), p21 (sc-397), Skp2 (sc-7164), p27 (sc-528), TIMP-1 (sc-5538), TIMP-2 (sc-5539), p-ERK1/2 (sc-16982), ERK (sc-94), p-JNK (sc-6254), JNK (sc-571), p-p38 (sc-17852-R), p38 (sc-7972) and β-actin (sc-47778) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). MMP-2 (ab92536) and MMP-9 (ab137867), HRP-conjugated anti-mouse (sc-516102) and anti-rabbit (sc-2004) secondary antibodies were purchased from Abcam (Cambridge, UK). The MEK1/2 inhibitor PD98059 was purchased from Calbiochem (San Diego, CA, USA). MTT was purchased from Sigma (St. Louis, MO, USA). All stock solutions were wrapped in foil and stored at −20 °C until use.
+ Open protocol
+ Expand
5

Western Blot Analysis of Rat Brain Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot tests were performed as previously reported [30 (link)]. Briefly, whole left hemispheres of rats in different groups were isolated and collected 24 h after SAH. After protein extraction, equal amounts of protein samples were loaded onto each lane of SDS-PAGE gel. After electrophoresis, the protein samples were transferred onto a nitrocellulose membrane for blocking and incubation at 4 °C overnight with the following primary antibodies: Anti-osteopontin (1:1000, sc-21742), anti-ERK 1/2 (phosphor-Thr202/Tyr204) (1:200, sc-16982), anti-ERK1/2 (1:2000, sc- 514302), and anti-β-actin (1:5000, I-19) from Santa Cruz Biotechnology Inc., TX, USA; anti-Beclin 1 (1:1000, NB500-249), anti-ATG 5 (1:500, NB110-53818), anti-LC3 (1:5000, NB600-1384) from Novus Biologicals, CO, USA; anti-FAK (phospho-Y397) (1:1000, ab81298), anti-FAK (1:1000, ab131435), anti-SQSTM1/p62 (1:5000, ab56416) from Abcam, Cambridge, MA, USA). Secondary antibodies used were anti-mouse (1:5000, sc-2031), anti-goat (1:5000, sc-2354) from Santa Cruz Biotechnology Inc., and anti-rabbit (1:5000, 2839792) from EMD Millipore Corporation, MA, USA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!